Prices for new US drugs doubled in 4 years, focusing on rare diseases

The Birmingham Star

May 26, 2025

BRUSSELS, Belgium: U.S. drugmakers are charging significantly more for new treatments, particularly those targeting rare diseases, as the median launch price for new pharmaceutical…